Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy?

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

February 1, 2019

Study Completion Date

May 1, 2019

Conditions
Muscle Disuse Atrophy
Interventions
DIETARY_SUPPLEMENT

Leucine

Participants will ingest 15g of leucine supplementation/day during the immobilisation period. Leucine supplementation will be administered in powdered form (Infinit Nutrition, Canada) and participants will be required to consume 5g of leucine mixed with 250-300 ml of water during each meal. Leucine is a dietary supplement according to the US FDA. This supplementation protocol has been demonstrated in humans (Murphy et al., 2016, AJCN) with no reported side effects. The quantity of leucine supplementation falls well within the safe limits outlined by Rasmussen et al. (2016). Infinit Nutrition Leucine is in compliance with banned substances requirements as espoused by the World Anti-Doping Agency. Infinit Nutrition Leucine is not a medicinal product.

DIETARY_SUPPLEMENT

Placebo

"Participants will ingest 15g of placebo supplementation/day during the immobilisation period. Placebo supplementation will be administered in powdered form and participants will be required to consume 5g of placebo supplementation mixed with 250-300 ml of water during each meal (3x/day).~Placebo supplementation will contain 5g of non-essential amino acids (Infinit Nutrition, Canada) and will be calorically matched to the leucine supplementation.This supplementation protocol has been demonstrated previously in humans, with no reported side effects (Murphy et al., 2016, AJCN)."

Trial Locations (1)

B15 2TT

University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences, Edgbaston

All Listed Sponsors
lead

University of Birmingham

OTHER

NCT03762278 - Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy? | Biotech Hunter | Biotech Hunter